期刊文献+

口服降糖药治疗失败的2型糖尿病患者的胰岛素的选择分析 被引量:3

Treatment Failure of OralHypoglycemic Agents in Patients with Type 2 Diabetes the Choice of Insulin
下载PDF
导出
摘要 目的:探究口服降糖药治疗失败的2型糖尿病患者的胰岛素的选择分析。方法:以口服降糖药控制不良的2型糖尿病患者为研究对象,患者在原有口服降糖药基础上,每天加用一次诺和锐(?)30注射(晚餐前注射),开始注射的剂量为12U,根据测定的血糖值调整胰岛素剂量,直至血糖达标。结果:采用双相门冬胰岛素在早餐后与晚餐后2h治疗前后血糖变化差异有统计学意义(P<0.05),其余时间治疗前后血糖与HbAlc差异无明显统计学意义(P>0.05)。结论:每天注射一次双相门冬胰岛素能有效治疗口服降糖药控制不良的2型糖尿病。 Objective: To learn the choose of insulin for patients of the type 2 diabetes mellitus because of the tailure of persral antidiabetic drugs. Methods: The patients of the type 2 diabetes mellitus, having persral antidiabetic drugs, are injected BIA aRer supper each day with first 12U. Regulating the dose due to blood sugar until it reached the standard. Results: There is difference having statistical significance between 2 hours after breakfast and supper by using BIA while the other hash' t. Conclusion: The type 2 diabetes mellitus, because of the failure of persral antidiabetic drugs, can be effectively treated by injecting BIA each day.
出处 《中国医药导刊》 2011年第9期1539-1539,1632,共2页 Chinese Journal of Medicinal Guide
关键词 2型 糖尿病 双相门冬胰岛素 BIAsp 30 诺和锐^(■)30 Type 2 Diabetes meHitus BIA BIAsp 30 Aspart^(■)30
  • 相关文献

参考文献3

二级参考文献17

  • 1陈奇盛,张萍,梁慧,蓝海云,陈蝉.2种胰岛素强化治疗方法治疗2型糖尿病的临床疗效比较[J].新医学,2006,37(11):725-727. 被引量:7
  • 2Hirsch IB. Intensifying insulin therapy in patients with type 2 diabetes mellitus[J]. Am J Med, 2005,118: 21S- 26S.
  • 3Hermansen K, Fontain P, Kukolja KK, et al. Insulin analogues(insulin determir and insulin aspart)versus traditional human insulins(NPH insulin and regular human insulin)in basal-bolus therapy in patients with type 1 diabetes[J]. Diabetologia, 2004,47:622-629.
  • 4Home P, Bartley P, Russell Jones D, et al. Insulin detemir offers improved glycaemic control compared with NPH insulin in people with type 1 diabetes[J]. Diabetes Care, 2004,27 : 1081-1087.
  • 5Philis-Tsimikas A, Charpentier G, Clauson P, et al. Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes[J]. Clin Ther,2006,28: 1569-1581.
  • 6Hermansen K, Davies M,Derezinski T,et al. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with 2 diabetes[J]. Care, 2006,29 : 1269-1274.
  • 7Pieber T,Dvaeger E, Kristensen A, et al. Comparison of three multiple injection regimens for type 1 deabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin[J]. Diabetes Med,2005,22:850-857.
  • 8Raslova K,Bogoev M,Raz I,et al. Insulin detemir and insulin aspart:a promissing basal-bolus regimen for type 2 diabetes[J]. Diab Res Clin Pract, 2004,66 : 193-201.
  • 9Haak T,Tiengo A,Draeger E, et al. Lower within-patient variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes [J]. Deabetes Obes Metab, 2005,7:56 -64.
  • 10Blonde L, Merilainen M, Karwe V, et al. Obesity and Metabolism[J]. Diabetes, 2009,11 : 623-631.

同被引文献22

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部